Sep 14, 2016
There are new concerns arising in Japan around drug pricing. Last April, the Japanese government introduced a re-pricing rule for “huge seller drugs” and proceeded to slash the reimbursement price for Gilead’s Solvaldi by a hefty 30%. The concern now among industry...
Sep 8, 2016
When a deal process is begun, the initial focus is on identifying good potential partners and getting them engaged in preliminary discussions. As one or more potential partners advance beyond these early discussions, the process moves into the critical due diligence...
Sep 1, 2016
If you are a business development professional, at some point in your career, it is very likely that you will be asked to organize and lead a sell-side strategic partnering process consistent with your company’s strategy and business development objectives. Having...
Aug 25, 2016
The foundation of any transaction is a negotiation between a buyer and seller around the fair value of an asset. The key to maximizing value in any transaction as a seller or buyer is a robust understanding of an asset’s underlying value. A valuation model is a...
Aug 17, 2016
A simple question plagues every deal maker – ‘Is this a good deal?’ Often it’s a matter of perception, viewed in the context of similar transactions or comparable companies. It can also be evaluated financially with a variety of methods incorporating discounted cash...
